Specifically, we identified two patients demonstrating chronically enhanced IFN signaling in blood and features of systemic sclerosis, a rare autoimmune disorder where IFN signaling and mtDNA have been suggested to play a role in pathogenesis (81–83). This evidence concerns the gene IFNA1 and systemic sclerosis.